Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine

Trends in Pharmacological Sciences

Volumn 28, Issue 11, 2007, Pages 551-555

  Rashid, Asim J ^a,b   O'Dowd, Brian F ^a,b   Verma, Vaneeta ^a   George, Susan R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CALCIUM ION; DIACYLGLYCEROL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GENISTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN GQ 11; SKF 83822; UNCLASSIFIED DRUG;

ADDICTION; AMYGDALOID NUCLEUS; ARTICLE; CALCIUM CELL LEVEL; CENTRAL NERVOUS SYSTEM DISEASE; EXPERIMENTAL MOUSE; MOLECULAR BIOLOGY; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROBIOLOGY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR SENSITIVITY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; DOPAMINE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; MODELS, BIOLOGICAL; NEURONS; RECEPTORS, DOPAMINE D1; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 35649005909     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.10.001     Document Type: Article

References (41)

1. Neve K.A., et al. Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24 (2004) 165-205
2. Gupta S.K., and Mishra R.K. The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices. Biochem. Int. 22 (1990) 887-894
3. Panchalingam S., and Undie A.S. SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain. Neuropharmacology 40 (2001) 826-837
4. Undie A.S., and Friedman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J. Pharmacol. Exp. Ther. 253 (1990) 987-992
5. Undie A.S., et al. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J. Neurochem. 62 (1994) 2045-2048
6. Wang H.Y., et al. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol. Pharmacol. 48 (1995) 988-994
7. Jin L.Q., et al. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J. Neurochem. 78 (2001) 981-990
8. Pacheco M.A., and Jope R.S. Comparison of [3H]phosphatidylinositol and [3H]phosphatidylinositol 4,5-bisphosphate hydrolysis in postmortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J. Neurochem. 69 (1997) 639-644
9. Ming Y., et al. Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons. J. Neurochem. 98 (2006) 1316-1323
10. Tang T.S., and Bezprozvanny I. Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons. J. Biol. Chem. 279 (2004) 42082-42094
11. Gu Z., and Yan Z. Bidirectional regulation of Ca2+/calmodulin-dependent protein kinase II activity by dopamine D4 receptors in prefrontal cortex. Mol. Pharmacol. 66 (2004) 948-955
12. Yan Z., et al. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11607-11612
13. Umemori H., et al. Activation of the G protein Gq/11 through tyrosine phosphorylation of the alpha subunit. Science 276 (1997) 1878-1881
14. O'Sullivan G.J., et al. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography. Eur. J. Pharmacol. 486 (2004) 273-280
15. Friedman E., et al. D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice. Mol. Pharmacol. 51 (1997) 6-11
16. Rashid A.J., et al. A novel dopamine receptor signaling unit with distinct pharmacology is coupled to rapid activation of Gq/11 in the striatum. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 654-659
17. Montague D.M., et al. Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice. Synapse 39 (2001) 319-322
18. Jin L.Q., et al. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J. Neurochem. 85 (2003) 378-386
19. Lee S.P., et al. Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 279 (2004) 35671-35678
20. Lezcano N., et al. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 287 (2000) 1660-1664
21. Lezcano N., et al. Retraction. Science 314 (2006) 1681
22. George S.R., et al. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1 (2002) 808-820
23. Neumeyer J.L., et al. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur. J. Pharmacol. 474 (2003) 137-140
24. Svenningsson P., et al. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons. Neuroscience 98 (2000) 749-757
25. Piomelli D., et al. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353 (1991) 164-167
26. Capper-Loup C., et al. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J. Neurosci. 22 (2002) 6218-6227
27. Seeman P., et al. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: implications for human positron emission tomography. Synapse 49 (2003) 209-215
28. Vivo M., et al. Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor. Mol. Pharmacol. 69 (2006) 226-235
29. Gingrich J.A., and Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16 (1993) 299-321
30. Undie A.S., and Friedman E. Aging-induced decrease in dopaminergic-stimulated phosphoinositide metabolism in rat brain. Neurobiol. Aging 13 (1992) 505-511
31. Levey A.I., et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8861-8865
32. Wong A.C., et al. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience 89 (1999) 221-233
33. Berridge M.J. Neuronal calcium signaling. Neuron 21 (1998) 13-26
34. Zhen X., et al. Regulation of cyclin-dependent kinase 5 and calcium/calmodulin-dependent protein kinase II by phosphatidylinositol-linked dopamine receptor in rat brain. Mol. Pharmacol. 66 (2004) 1500-1507
35. Thomas M.J., and Malenka R.C. Synaptic plasticity in the mesolimbic dopamine system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 (2003) 815-819
36. Arnold S.E., et al. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog. Brain Res. 147 (2005) 319-345
37. Andringa G., et al. Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology (Berl.) 146 (1999) 328-334
38. Gnanalingham K.K., et al. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Psychopharmacology (Berl.) 117 (1995) 287-297
39. Platt D.M., et al. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J. Pharmacol. Exp. Ther. 293 (2000) 1017-1026
40. Seeman P., et al. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 10156-10160
41. Lidow M.S. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Brain Res. Rev. 43 (2003) 70-84